Clinical Trial Update: Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing filgrastim to placebo after allogeneic bone marrow transplantation; graft-versus-host disease is the listed condition and the current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Centre National de Greffe de Moelle Osseuse | Conditions: Graft vs Host Disease | Phase 3 | Status: UNKNOWN